NIHR Maudsley BRC Blog

Our latest news & events

Novavax trial reveals 89.3% effectiveness in preventing COVID-19

Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.

By King's CRF at 29 Jan 2021

Antibiotic may improve outcomes for depression in people with low level inflammation

King’s College London researchers have found evidence that minocycline, a widely used antibiotic with anti-inflammatory properties, gave greater improvement in depressive symptoms in patients with treatment resistant depression with low-grade peripheral inflammation.

 

By NIHR Maudsley BRC at 28 Jan 2021

SIREN study finds past COVID-19 infection provides some immunity for at least five months

The first report from Public Health England's national SIREN study, supported at King's College Hospital by the King's CRF, has found that past COVD-19 infection provides 83% immunity for at least five months. However, some people may still carry the virus and transmit to other people.

By NIHR Wellcome King's Clinical Research Facility at 19 Jan 2021

New swabbing pod open at King's CRF

A new swabbing pod has been installed next to the Clinical Trials Facility at King’s College Hospital so that outpatients and trial participants who are symptomatic or have tested positive for COVID-19 can continue to receive treatment or attend follow-up appointments.

By NIHR Wellcome King's Clinical Research Facility at 8 Dec 2020

Heroin injection associated with respiratory disorder

A single case study of an individual with longstanding heroin addiction has shown heroin-induced slow and ineffective breathing, as well as apnoea, in research from the NIHR Maudsley BRC.

By NIHR Maudsley BRC at 26 Mar 2020